Activation of the endocannabinoid system by organophosphorus nerve agents.
about
Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genesBiochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12)Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effectsOrganophosphate-sensitive lipases modulate brain lysophospholipids, ether lipids and endocannabinoidsEndocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathwaysChemical probes of endocannabinoid metabolismMonoacylglycerol lipase - a target for drug development?Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionDiscovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory PainStructural Characterization and High-Throughput Screening of Inhibitors of PvdQ, an NTN Hydrolase Involved in Pyoverdine SynthesisInhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future AntidepressantsElevating endocannabinoid levels: pharmacological strategies and potential therapeutic applicationsMultidimensional profiling platforms reveal metabolic dysregulation caused by organophosphorus pesticidesLow level chlorpyrifos exposure increases anandamide accumulation in juvenile rat brain in the absence of brain cholinesterase inhibitionEffect of developmental chlorpyrifos exposure, on endocannabinoid metabolizing enzymes, in the brain of juvenile ratsBehavioral sequelae following acute diisopropylfluorophosphate intoxication in rats: comparative effects of atropine and cannabinomimeticsInduction of endocannabinoid levels in juvenile rat brain following developmental chlorpyrifos exposureChronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system.Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2Mass spectrometry identifies multiple organophosphorylated sites on tubulin.Activity-based probes for monitoring postproline protease activity.Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolismMonoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis.Metabolomic strategies to map functions of metabolic pathwaysOveractive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteinsChemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoidsBiosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.Exploring metabolic pathways and regulation through functional chemoproteomic and metabolomic platformsMetabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways.Activity-based protein profiling of organophosphorus and thiocarbamate pesticides reveals multiple serine hydrolase targets in mouse brainHigh-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolaminesEndocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation.Mapping proteome-wide interactions of reactive chemicals using chemoproteomic platforms.Mapping Proteome-Wide Targets of Environmental Chemicals Using Reactivity-Based Chemoproteomic PlatformsThe CB(1) cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axisMammalian alpha beta hydrolase domain (ABHD) proteins: Lipid metabolizing enzymes at the interface of cell signaling and energy metabolism.Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels.Pharmacological enhancement of endocannabinoid signaling reduces the cholinergic toxicity of diisopropylfluorophosphate.Endocannabinoid signaling in microglial cells
P2860
Q21090979-9AD0B9F8-7C6C-464D-90D2-CAFB390F8A77Q24298516-2C9A645F-BC7E-4312-9550-E9B32D3EBF4AQ24569799-EA8E412D-8B93-4C4B-AE2F-E8B37CC888D1Q24658124-F4AF46F3-DDE0-4231-8B40-116A01CCAEBBQ26823256-575BA208-9EBA-4C74-BEDD-AB367A6A9FCBQ26863202-D1A83A71-65BC-49A0-A261-D67D097559AFQ26998964-3940ADA5-FF1D-4574-9B44-8F626139642CQ27014154-F6E60EAB-A539-42AB-9AE6-190D62B54701Q27655121-1EF48B3F-802A-41E2-9C5E-D8DF39B9FBCDQ27673090-BB973895-8EEF-4C2D-9D83-FB62411CADF7Q28082891-14F8CB87-62D2-4142-8789-17F5EED6029DQ28300390-E9E7EB52-8D3C-4D80-810F-75D9073B9BCFQ28387124-02A6BD5F-7E80-423C-B40F-ACC53E93A65DQ28388698-F625B046-BF1C-4B42-B81B-5DBE13DDE692Q28390570-4B7E7175-0106-4F4C-8FC6-519907CA8AE5Q28394730-57C39033-EB20-49BB-ADE6-07447805836CQ28397630-A7B40C5E-9CFE-488B-83D0-849E33DAAAC3Q28590486-768F6D89-094F-4F16-84C1-43DF76805790Q30492114-CA47C1B4-E00D-4017-85B7-FE1EAB776B49Q30981876-9C823C06-F4DC-4F97-AE71-537AB3B8F72CQ33486958-078E9CF9-94A9-469C-A74D-61521728AE88Q33761011-0740ED8D-6568-4C49-AEA5-5FD0680C8C35Q33840797-545028FA-0952-4589-8742-67E40D5CECDAQ33914549-2CD67067-DFD3-4F47-8F8F-EC0FA78C16AEQ34001321-B709EB0F-CDAF-49EE-B71E-3185BF7B7473Q34013800-D5DF412E-76E2-490C-B173-A0085A31D02CQ34156640-1C49A689-88B8-447E-A70D-B0EF9DB4BEEEQ34165188-1F345687-D301-40EF-BB2D-EA7C98F9C086Q34228026-94213CDE-FC35-4A40-9477-1EB7B3C8F144Q34328745-4AE860EB-5BF8-4733-A8C1-306DBEFF4A3BQ34768166-1DDCEF89-C5F5-4503-ACC4-F16645640020Q35490988-88FD1D1D-EB81-4EFA-A22F-B0BA85C19DCAQ35645037-7637F5AD-7A62-4F94-A912-B03202C28233Q35863703-61D26D65-9519-4407-8895-07C21E6F1773Q36210400-32BCE21D-E7A0-44BD-94E2-44BA0EA5BFF7Q36533324-1E383C64-85AA-4827-AA5D-1D89CD281CD3Q36612260-503713DB-1023-4539-A4D1-CEB916C3188EQ36995471-9E56CF50-287E-4E17-B57B-A6456F9ADE6DQ37137506-AFDBA3A3-001C-4427-B400-EE30B2BACE87Q37250243-14C8BA1A-E3BF-4BFF-96C7-B5C923606A22
P2860
Activation of the endocannabinoid system by organophosphorus nerve agents.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Activation of the endocannabinoid system by organophosphorus nerve agents.
@ast
Activation of the endocannabinoid system by organophosphorus nerve agents.
@en
Activation of the endocannabinoid system by organophosphorus nerve agents.
@nl
type
label
Activation of the endocannabinoid system by organophosphorus nerve agents.
@ast
Activation of the endocannabinoid system by organophosphorus nerve agents.
@en
Activation of the endocannabinoid system by organophosphorus nerve agents.
@nl
prefLabel
Activation of the endocannabinoid system by organophosphorus nerve agents.
@ast
Activation of the endocannabinoid system by organophosphorus nerve agents.
@en
Activation of the endocannabinoid system by organophosphorus nerve agents.
@nl
P2093
P2860
P356
P1476
Activation of the endocannabinoid system by organophosphorus nerve agents.
@en
P2093
Anna M Ward
Daniel K Nomura
Gabriel M Simon
Jacqueline L Blankman
John E Casida
Kazutoshi Fujioka
Roger S Issa
P2860
P2888
P304
P356
10.1038/NCHEMBIO.86
P577
2008-04-27T00:00:00Z